<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211224053503N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-01-04</date_registration>
      <primary_sponsor>College of Nursing, University of Baghdad</primary_sponsor>
      <public_title>Preoperative Incentive Spirometer Breathing Exercise to Prevent Postoperative Pulmonary Complications</public_title>
      <acronym>IST</acronym>
      <scientific_title>Effectiveness of Incentive Spirometer on The Prevention of Postoperative Pulmonary Complications following Cardiac Surgeries</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-01-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>128</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60920</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Prevention, Randomization description: Parallel group trials design was used, in which subjects were randomly assigned to study group and control group. 
Unit of randomization : Individual 
Simple randomization technique was used for the assignment of subjects into a particular group.
flipping a coin method was chosen (heads - control, tails - intervention), Blinding description: The study is single-blinded, since the participants are intentionally kept  unaware of which of the two groups ( study and control groups) they have been assigned.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Postoperative pulmonary complications.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The starting point of the intervention phase will start by instructing patients undergoing open heart surgeries to use Incentive Spirometer (IS) which is a mechanical device that provides patients with visual reinforcement to inhale in a deep and slow manner to enhance lungs reinflation which treat or prevent atelectasis, intervention group will use the IS hourly while awake for two days prior to surgery  .The intervention group will be observed for 7 days to see the influence of the given intervention on preventing pulmonary complications. Intervention 2: Control group: Control group will not use Incentive Spirometer(IS) before surgery ,instead they will receive the standard usual care provided by health care professionals. Control group will be be observed for 6 days to compare the incidence of postoperative pulmonary complications with those of the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The researcher is acknowledging the scientific community to have verifiable findings of the study. sharing plan includes making all the related data available through publishing the study report in peer-reviewed reputable journals.

When:
God willing, once finishing the process of data collection, analysis and successfully publishing the manuscript, all the related files will become available for 6 months after publications

To whom:
All the related files will be shared with any scientific interested parties.

Conditions:
It may be used after seeking the author's permission and acknowledging his contribution.

Where to obtain:
The author's professional e-mail that will be available with the published manuscript can be used to contact the author. e-Mail: jadeel.nour1202a@conursing.uobaghdad.edu.iq

How to obtain:
N/A

Comments:
Profound appreciations are due to the IRCT members for their genuine efforts in helping researchers fulfilling their academic endeavors</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Jadeel Al-Tuwaij</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bab AL-Muadum</address>
        <city>Baghdad</city>
        <country1>Iraq</country1>
        <zip>10001</zip>
        <telephone>+964 1 521 1494</telephone>
        <email>jadeel.nour1202a@conursing.uobaghdad.edu.iq</email>
        <affiliation>College of Nursing, University of Baghdad</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Jadeel Al-Tuwaij</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bab AL-Muadum</address>
        <city>Baghdad</city>
        <country1>Iraq</country1>
        <zip>10001</zip>
        <telephone>+964 1 521 1494</telephone>
        <email>jadeel.nour1202a@conursing.uobaghdad.edu.iq</email>
        <affiliation>College of Nursing, University of Baghdad</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
      <country2>Iraq</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients who will agree to participate in the study based on their informed consent .
Subjects with age &gt;50 years.
Patients who undergo open heart surgery including ( coronary and valvular) procedures</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>79 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who refuse to participate in the study.
Patients who have thoracic, abdominal, or cerebral aneurysms
recent cardiothoracic or abdominal surgery.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The starting point of the intervention phase will start by instructing patients undergoing open heart surgeries to use Incentive Spirometer (IS) which is a mechanical device that provides patients with visual reinforcement to inhale in a deep and slow manner to enhance lungs reinflation which treat or prevent atelectasis, intervention group will use the IS hourly while awake for two days prior to surgery  .The intervention group will be observed for 7 days to see the influence of the given intervention on preventing pulmonary complications.</i_keyword>
      <i_keyword>Control group: Control group will not use Incentive Spirometer(IS) before surgery ,instead they will receive the standard usual care provided by health care professionals. Control group will be be observed for 6 days to compare the incidence of postoperative pulmonary complications with those of the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The incidence of postoperative pulmonary complications. Timepoint: Subjects response to the  intervention will be within one week of the first meeting to examine the effectiveness of the intervention on preventing pulmonary complications. Method of measurement: Diagnosis of pulmonary complications from patients' records, results of Peak Expiratory Flow Rate and Arterial Blood Gases.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Peak Expiratory Flow Rate (PEFR). Timepoint: Secondary outcome is measured before and after the application of intervention within one week. Method of measurement: Data will be obtained from patient's records.</sec_outcome>
      <sec_outcome>Arterial Blood Gases. Timepoint: Secondary outcome is measured before and after the application of intervention within one week. Method of measurement: Data will be obtained from patient's records.</sec_outcome>
      <sec_outcome>Hospital length of stay. Timepoint: Secondary outcome is measured  after the application of intervention within one week. Method of measurement: Data will be obtained from patient's records.</sec_outcome>
      <sec_outcome>Oxygen dependency. Timepoint: Secondary outcome is measured  after the application of intervention during the postoperative phase. Method of measurement: Observation, medical records.</sec_outcome>
      <sec_outcome>Intensive Care Unit stay. Timepoint: Secondary outcome is measured  after the application of intervention during the postoperative phase in the intensive care unit. Method of measurement: Data will be obtained from patient's records.</sec_outcome>
      <sec_outcome>Prolonged ventilation. Timepoint: Secondary outcome is measured  after the application of intervention during the postoperative phase in the intensive care unit. Method of measurement: Data will be obtained from patient's records.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The author of the trial is the funding source</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-12-08</approval_date>
        <contact_name>Research Ethical Approval Committee, at the College of Nursing</contact_name>
        <contact_address>Bab AL-Muadum Baghdad Baghdad Iraq</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
